Genelux | Investor Presentation Deck | 38 slides · page 17 of 38
The slide uses a cross-trial comparison to highlight the efficacy of Olvi-Vec in heavily pre-treated patients compared to other standard regimens.
Pitch deck · key_takeaways · summarize · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 1/1 list 1/1 source-note 1/1 table 1/1 title 1/1
Components 5
bar-grouped bullet source-note data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1